PROMIS study endorses mpMRI prior to prostate biopsy for many patients

Posted on January 19, 2017 by Sitemaster

The PROMIS study is a UK-based study designed to confirm earlier data suggesting that having a multiparametric MRI (mpMRI) scan could really help to decide which men needed a prostate biopsy because they really did or didn’t have prostate cancer. … READ MORE …

Filed under: Diagnosis, Management, Risk | Tagged: , , , , , | 10 Comments »

The Thursday news report: March 5, 2009

Posted on March 5, 2009 by Sitemaster

There are a significant number of relatively long-term news items in today’s report. Of most immediate interest to the majority of prostate cancer patients and educators we include reports on:

  • The fact that over 70 percent of cancers thought to be unilateral at biopsy turn out to be bilateral post-surgery (which has implications for focal therapy)
  • The availability of degarelix for actual prescription and clinical use in the USA
  • The formation of a specialized new urologic oncology research institute at UCLA … READ MORE …

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , | 3 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives